MELBOURNE, Australia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr Megan Baldwin, the Companyâs Chief Executive Officer, will participate in a fireside chat at the SVB Leerink Global Healthcare Conference, being held virtually from February 14-18, 2022.
The presentation will be available beginning Thursday, Febr...
>>> Read more: Opthea To Present at SVB Leerink Global Healthcare Conference
The presentation will be available beginning Thursday, Febr...
>>> Read more: Opthea To Present at SVB Leerink Global Healthcare Conference
